Cocrystal Pharma

Cocrystal Pharma is a clinical-stage biotechnology company that discovers and develops novel antiviral therapies targeting the replication processes of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C virus, and norovirus. Cocrystal leverages a unique structure-based technology and Nobel Prize-winning expertise to create first-in-class antiviral drugs.